KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash & Equivalents (2016 - 2025)

Encompass Health (EHC) has disclosed Cash & Equivalents for 17 consecutive years, with $72.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 15.46% year-over-year to $72.2 million, compared with a TTM value of $72.2 million through Dec 2025, down 15.46%, and an annual FY2025 reading of $72.2 million, down 15.46% over the prior year.
  • Cash & Equivalents was $72.2 million for Q4 2025 at Encompass Health, up from $48.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $223.9 million in Q1 2021 and bottomed at $21.8 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $95.8 million, with a median of $85.2 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents tumbled 85.4% in 2021, then surged 216.97% in 2023.
  • Year by year, Cash & Equivalents stood at $49.4 million in 2021, then tumbled by 55.87% to $21.8 million in 2022, then soared by 216.97% to $69.1 million in 2023, then increased by 23.59% to $85.4 million in 2024, then fell by 15.46% to $72.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for EHC at $72.2 million in Q4 2025, $48.7 million in Q3 2025, and $99.1 million in Q2 2025.